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Abstract 
Background: Obesity affects cardiovascular morbidity and mortality, and it increases 
the risk of coronary artery disease. Despite that, several cardiac surgery risk 
stratification scores do not consider the effect of obesity on the outcomes. The 
objective of this research is to study the impact of body mass index (BMI) on morbidity 
and mortality after coronary artery bypass grafting (CABG) in Egyptian patients. 
Methods: This prospective cohort study included 200 patients who underwent CABG 
for atherosclerotic coronary artery disease. Patients were divided into two groups, 
group A: patients with BMI ≥ 25 Kg/m2 and group B: patients with BMI < 25 Kg/m2. The 
mean age in group A was 56± 4.95 years vs. 54± 5.5 years in group B (p= 0.102). Male 
patients presented 58% of the population in group A vs 74% in group B (p= 0.017). 60% 
of patients were hypertensive in group A compared to 63% in group B (p= 0.66) and 
62%, and 48% were diabetics in group A and B respectively (p= 0.04).
Results: Postoperatively, there was a significant increase in wound infection (40% vs 
8%; p< 0.001), chest infection (47% vs. 10% p< 0.001), surgical re-exploration (28% vs. 
1%; p< 0.001), prolonged ICU stays (5.3 ± 2.88 vs. 3.93 ± 1.71 days; p< 0.001), ward stay 
(11.28 ±8.9 vs. 5.48 ± 2.45 days; p< 0.001), mediastinitis (34% vs. 6%; p< 0.001), the 
occurrence of sternal wound sinus within 8 months (26% vs. 7%; p< 0.001), in group A 
more compared to group B. There was no difference in ejection fraction (54.2 ±7.38 vs. 
54.7 ± 9.1%; p= 0.69) and mortality (4% vs. 2%; p= 0.68) between groups.  
Conclusions: BMI 25 Kg/m2 or higher is associated with increased infectious 
complications and prolonged stay after CABG; however, it did not affect mortality. 
Optimizing body weight is recommended before elective surgery. 
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Introduction 
The prevalence of obesity is increasing 
worldwide, producing significant repercussions in 
cardiovascular disease, morbidity, mortality and 
healthcare costs [1, 2]. Obesity with increasing 
waist diameter is significantly associated with an 
increased risk for coronary artery disease (CAD) 
[3]. Coronary artery bypass grafting (CABG) 
remains the standard of care in the management 
of advanced CAD, and it is associated with 
improved quality of life and reduced cardiac-
related mortality [4]. Several studies found that 
obese patients have a higher incidence of 
morbidity and mortality after CABG [5].  
Body mass index (BMI) was classified 
according to the World Health Organization 
(WHO) into three groups: normal weight (BMI 
between 18.5 and 24.9 kg/m2), overweight (BMI ≥ 
25 Kg/m2 and < 30 Kg/m2), and obese (BMI ≥ 30 
Kg/m2) [6, 7]. Although higher BMI was 
associated with major morbidity and increased 
the cost of healthcare, BMI is not included in 
several cardiac risk stratification scores [8]. This 
study aims to evaluate the effect of BMI on early 
and late morbidity and mortality after CABG in 
the Egyptian population.  
Patients and Methods: 
This is a prospective cohort study that included 
200 adult patients who underwent CABG at Benha 
University Hospital and the National Heart 
Institute from January 2018 to January 2019. The 
study was approved by the Ethical Committee of 
Benha Faculty of Medicine, and written consent 
was obtained from all patients. All patients were 
followed up for eight months postoperatively. 
Exclusion criteria included age <30 years, 
concomitant cardiac procedures, end stage renal 
and hepatic disease and left ventricular ejection 
fraction (LVEF) < 35%. Patients were divided into 
two groups according to their BMI; group A 
included patients with BMI ≥ 25 Kg/m2 and group 
B had patients with BMI < 25 Kg/m2. Preoperative, 
operative and postoperative data were 
prospectively collected and entered into a 
computerized database. 
Data collection:  
Preoperative data included patients’ 
demographics and co-morbidities. Preoperative 
echocardiography data included ejection fraction 
(EF), left ventricular end diastolic dimension 
(LVEDD) and left ventricular end systolic 
dimension (LVESD), systolic wall motion 
abnormalities (SWMA). Routine laboratory 
investigations were done for all patients; 
additionally, the requirements for preoperative 
inotropic support and intra-aortic balloon pump 
(IABP) were recorded. 
Operative data included the urgency of the 
intervention, the use of cardiopulmonary bypass 
(CPB) (on-pump vs off-pump CABG), 
cardiopulmonary bypass and aortic cross-clamp 
(ACC) time and the type of conduits used; in 
addition to the need for inotropic support and 
IABP. 
Post-operative data included; duration of 
mechanical ventilation, intensive care unit (ICU) 
stay and mortality. Post-operative complications 
included arrhythmia, MI (diagnosed by new Q 
wave on ECG and rise in CPK-MB), re-exploration 
for bleeding, neurological complications (stroke), 
pulmonary complications (pulmonary infection, 
atelectasis and re-intubation) and wound 
complications (sternotomy wound infection 
and/or dehiscence, mediastinitis diagnosed when 
exploration and debridement were required for 
deep sternal infection). 
Surgical technique: 
Conventional anesthetic and cardiopulmonary 
bypass techniques were standardized for all 
patients in both groups. A median sternotomy was 
used in all patients. Aortic and two-stage right 
atrial cannulation were used. Left internal 
mammary artery (LIMA) and saphenous vein were 
harvested conventionally. We did not use the 
bilateral internal mammary artery (BIMA) to 
decrease the risk of deep sternal wound infection.  
Intermittent antegrade cold and warm blood 
cardioplegia were delivered every 25 minutes. 
LIMA was grafted to the left anterior descending 
coronary artery (LAD) and saphenous vein grafts 
for the other anastomosis. Following distal 
anastomoses, proximal ones were done during 
reperfusion with the aorta partially clamped. 
During CPB time, hematocrit levels were 
maintained above 20%. Three drains were 
inserted before chest closure, two mediastinal and
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Table 1: Preoperative Data: Continuous variables are presented as mean± SD and range. Categorical variables are 
presented as number and percentage. * indicate significant difference between the groups (p < 0.05). 
Group A (n=100) Group B (n=100) P 
Age (years) 56.12 ± 4.95 (43 - 69) 54.9 ± 5.53 (39 - 68) 0.102 
Male 58 (58%) 74 (74%) 0.017* 
Hypertensives 60 (60%) 63 (63%) 0.66 
Diabetics 62 (62%) 48 (48%) 0.04* 
EDD (cm) 6 ± 4.58 (3.9- 5.1) 5.56± 0.52 (4.1- 7) 0.34 
ESD (cm) 3.61± 0.49 (2.5- 5.1) 3.69± 0.52 (2.3- 5.4) 0.22 
EF (%) 53.3± 6.3 (40-69) 55± 7.2 (40-80) 0.07 
CAD 
One vessel disease 2 (2%) 2 (2%) 
0.012* 
Two vessel disease 16 (16%) 5 (5%) 
Three-vessel disease 59 (59%) 78 (78%) 
Four-vessel disease 23 (23%) 15 (15%) 
CAD: Coronary artery disease; EDD; End diastolic diameter; EF: Ejection fraction; ESD: End systolic 
diameter 
one in the left pleural space. Patients were 
extubated in ICU after regaining consciousness 
with good motor power, satisfactory arterial blood 
gases (ABG) and hemodynamic stability. 
Regulation of blood glucose level was achieved by 
continuous intravenous insulin infusion to 
maintain glucose level below 200mg /dl. 
Statistical analysis 
The collected data were summarized as mean 
± standard deviation (SD) and range (minimum-
maximum) for quantitative data and frequency 
and percentage for qualitative data. Comparisons 
between the different study groups were carried 
out using the Chi-squared test (χ2) and the Fisher 
Exact Test (FET) to compare proportions as 
appropriate, the Independent t-test (t) was used 
to detect the difference between parametric 
quantitative data. The statistical analysis was 
conducted using SPSS version 21 (IBM 
Corporation, Chicago, IL, USA).
Table 2: Intraoperative Data: Continuous variables are presented as mean± SD and range. Categorical variables 
are presented as number and percentage. * indicate significant difference between the groups (p < 0.05). 
Group A (n=100) Group B (n= 100) P 
Cardiopulmonary bypass time (min) 118 ± 35.4 (50-220) 115.7 ± 29 (60-180) 0.61 
Cross clamp time (min) 76.17 ± 21.7 (35- 130) 27.5 ±18.8 (45-150) 0.21 
IABP 23 (23%) 2 (%) <0.001* 
Graft 
One graft 2 (2%) 3 (3%) 
0.06 
Two grafts 16 (16%) 11 (11%) 
Three grafts 58 (58%) 74 (74%) 
Four grafts 24 (24%) 12 (12%) 
Inotropes 
No used 3 (3%) 0 
0.27 
One inotrope 15 (15%) 19 (19%) 
Two inotropes 47 (47%) 47 (47%) 
Three inotropes 35 (35%) 32 (32%) 
Four inotropes 0 2 (2%) 
IABP: intra-aortic balloon pump 
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Table 3: Early postoperative data: Continuous variables are presented as mean± SD and range. Categorical variables are 
presented as number and percentage. * indicate significant difference between the groups (p < 0.05). 
Group A (n=100) Group B (n=100) P 
Duration of mechanical ventilation (hours) 18.78 ± 22.7 (4- 168) 9.32 ± 6.12 (5- 48) <0.001* 
ICU stay (days) 5.3 ± 2.88 (2- 18) 3.93 ± 1.71 (3- 14) <0.001* 
Ward stay 11.28 ±8.9 (3- 30) 5.48 ± 2.45 (2- 15) <0.001* 
Mortality 4 (4%) 2 (2%) 0.68 
Results 
Preoperative data 
There was no statistically significant difference 
between the studied groups regarding mean age 
(p=0.102) or hypertension (p=0.66). Group A had 
more patients with diabetes (p= 0.04). There was 
no significant difference in echocardiographic data 
between groups. However, the distribution of 
CAD differed significantly (p= 0.012) (Table 1). 
Operative data  
There were no significant differences in CPB 
time (p=0.61) and aortic cross-clamping 
time (p=0.21) between groups (Table 2).  
Postoperative data 
Duration of mechanical ventilation, ICU and 
ward stay were significantly higher in group A (p< 
0.001) but no difference in mortality (p= 0.68) 
(Table 3).  
There was a significant difference between 
both groups as regard to wound infection, chest 
infection, stroke, surgical re-exploration and the 
occurrence of sternal wound sinus within eight 
months (P<0.001). No liver or renal impairment 
had occurred in both groups. There was no 
significant difference in mean ejection fraction 
postoperatively (P=0.69) between the 
studied groups (Table 4). 
Discussion 
Despite the risk of obesity on cardiovascular 
disease, it is not included in several cardiac surgery 
risk stratification tools. The purpose of this study 
was to evaluate the effect of increased BMI on the 
outcomes after CABG in the Egyptian population. 
The study included 200 adult patients who 
underwent isolated CABG. They were classified 
into two groups according to BMI; group A 
included patients with BMI ≥ 25 kg/m2 and group 
B had patients with BMI < 25 kg/m2. There were 
no underweight patients (BMI ˂ 20 kg/m2) 
included in the study.  
There was no statistically significant difference 
between the studied groups regarding age or 
hypertension. Meanwhile, there was a statistically 
significant difference regarding sex and DM 
distribution. Male gender predominated in both 
groups; however, group A had more females than 
group A, a finding which is consistent with a 
previous Study [9]. 
Table 4: Late postoperative complications: Continuous variables are presented as mean± SD and range. Categorical 
variables are presented as number and percentage. * indicate significant difference between the groups (p < 0.05). 
Group A (n=96) Group B (n= 98) P 
Wound infection 38 (40%) 8 (8.1%) <0.001* 
Mediastinitis 33 (34%) 6 (6%) <0.001* 
Chest infection 45 (47%) 10 (10) <0.001* 
Stroke 14 (15%) 0 <0.001* 
Re-exploration 27 (28%) 1 (1%) <0.001* 
Sternal wound sinus 25 (26%) 7 (7%) <0.001* 
EF (%) 54.2 ±7.38 (40- 69) 54.7 ± 9.1 (40-70) 0.69 
EF: Ejection fraction 
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Although obesity is associated with younger 
patients undergoing CABG [10, 11], this study did 
not show a difference between overweight and 
normal weight Egyptian patients undergoing 
CABG. 
Smoking is more common in normal weight 
patients [9, 10, 12] which could confound the 
effect of obesity on the results of surgery. 
Consistent with previous studies [9, 11, 12], 
diabetes is more common in obese patients which 
contribute to the increased severity of the 
coronary artery disease and further increase the 
risk of surgery.  We apply strict measures to 
control blood sugar level preoperatively in elective 
surgery and our target HbA1C is less than 7.5. 
Obesity increases the risk of hypertension and for 
every one-kilogram increase in body weight, an 
increase of blood pressure by 1 mmHg occurs 
[12]. Several studies confirmed the association 
between hypertension and obesity [9,11,12] 
which was not elicited by our study. This could be 
attributed to the difference in sex distribution 
between groups, in addition, the study did not 
include patients with markedly elevated BMI.  
Moreover, we excluded all patients with chronic 
diseases and end organ damage such as liver or 
renal diseases. 
Patients with increased BMI had significantly 
more severe CAD, a finding that could be 
attributed to the obesity itself or the associated 
increase in DM in this group [13]. Despite the 
difference in the preoperative patients’ 
characteristics, operative data were comparable 
between groups. This finding is consistent with 
other studies [9, 11, 13] and could be attributed 
in our study to the standardized anesthetic and 
CPB techniques used in all patients, in addition, 
we did not use BIMA in all patients to decrease 
the risk of infectious complications.  
In early postoperative period, ventilation time, 
ICU and hospital stay were significantly higher in 
group A. Obesity was found to be associated with 
prolonged mechanical ventilation [8] and several 
mechanisms contributed to this. Obese patients 
had slower return to their consciousness and 
restoration of the muscle power and many 
anesthetic agents are fat soluble with prolonged 
duration of action in obese patients due to 
redistribution.  
Re-exploration occurred more in group A 
which is inconsistent to previous studies [9, 12]. 
Group A had more patients with 4 grafts which 
increased the number of anastomosis and could 
contribute to the postoperative bleeding risk. We 
did not find significant difference in infection rate 
at the site of vein harvest between groups; 
however, other infectious complications were 
significantly higher with the increased BMI group. 
Infectious complications were inconsistently 
reported in obese patients in the literature. [9- 
12,14-15] The difference in the reported 
infectious complications rate in the literature 
could be attributed to different patients’ 
population and surgical techniques among the 
published series. Additionally, several preventive 
measures were applied to prevent infectious 
complications in this subset of patients [16].  
Neurological complications were significantly 
higher in group A which is consistent with 
previous studies [9, 10, 12]. Obese patients have 
more risk of diabetes and vascular disease which 
increase the risk of neurological complications. 
This effect can be due to the obesity itself or the 
associated co-morbidity. Postoperative 
complications tend to occur more frequently with 
higher BMI patients; however, this did not affect 
the overall mortality. Previous study showed an 
increased mortality in obese patients [17] and 
this was attributed to the severity of CAD in these 
patients. Obesity can affect long-term survival 
which was not studied in our series. 
In summary; obesity had a negative impact on 
the outcomes after CABG with marked increase in 
the infectious complications. Preoperative 
optimization of this subset of patients and 
additional aseptic precaution could decrease the 
risk of these complications. 
Study limitations: 
The study has several limitations including short 
term follow-up and the effect of obesity on long-
term survival and revascularization rate could not 
be evaluated. Longer study of these outcomes is 
recommended. Another limitation is the small 
number of patients, despite the detection of 
significant difference between groups, the 
number of events was too small to power the 
multivariable analysis to balance the difference in 
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baseline patients’ characteristics and identify the 
independent effect of obesity on the outcomes. 
Conclusion 
BMI 25 Kg/m2 or higher is associated with 
increased infectious complications and prolonged 
stay after CABG; however, it did not affect 
mortality. Optimizing body weight is 
recommended before elective surgery. 
Conflict of interest: Authors declare no conflict of 
interest. 
References 
1. Chen Z, Yang G, Offer A, et al. Body mass index
and mortality in China: a 15-year prospective
study of 220 000 men. Int J Epidemiol. 2012;
41: 472–481.
2. Zheng W, Mclerran DF, Rolland B, et al.
Association between body-mass index and risk
of death in more than 1 million Asians. N Engl
J Med. 2011; 364: 719-729.
3. National Centre for Health Statistics. The Third
National Health and Nutrition Examination
Survey, NHANES111 (1988-94) [Accessed NOV
14, 2014]. Available from: 
http://www.cdc.gov/nchs/nhnanes.html. 
4. Harskamp RE, Alexander JH, Ferguson TB Jr, et
al. Frequency and predictors of Internal
Mammary Artery Graft Failure and
Subsequent clinical outcomes: Insights from
the PREVENT IV Trial. Circulation.2016; 133 (2):
131-8.
5. Kunadian B, Dunning J, Millner RWJ.
Modifiable risk factors remain significant
causes of medium-term mortality after first-
time coronary artery bypass grafting. J
Cardiothorac Surg 2007; 2 (1): 51
6. Who J and Consultation FE. Diet, nutrition and
the prevention of chronic diseases. World
Health Organ Tech Rep Ser. 2003;916:i-viii, 1-
149, back cover.
7. Organization WH. WHO global database on
body index (BMI). An interactive surveillance
tool for monitoring nutrition. 2006.
8. Ghanta R K, Lapar DJ, Zhang Q, et al. Obesity
Increase Risk –Adjusted Morbidity, Mortality,
and cost following Cardiac Surgery. J AM heart
Asso. 2017, 6 (3), e003831.
9. Abdallah AG, Elnewihy MA, Brik AI Salem
AMM. Impact of obesity on early cardiac
surgical outcomes in Egypt׃ Early outcomes of
coronary artery bypass graft surgery. Egypt.
Soc. Cardiothorac. Surg. 2017; 25: 192-197.
10. Engel AM, McDonough S, Smith JM. Does an
obese body mass index affect hospital
outcomes after coronary artery bypass graft
surgery? Ann Thorac Surg. 2009; 88 (6): 1793-
1800. 
11. Ardeshiri M, Faritous Z, Haghighi ZO, et al.
Effect of obesity on mortality and morbidity
after coronary artery bypass grafting surgery
in Iranian patients. Anesth Pain Med. 2014; 4
(2): e18884.
12. Tokmakoglu H. Operative and early results of
coronary artery bypass grafting in female
patients in different body mass indexes. J
Cardiothorac Surg, 2010; 5: 119.
13. Wang TKM, Ramanathan T, Stewart R, et al.
Lack of relationship between obesity and
mortality or morbidity after coronary artery
bypass grafting. N. Z Med J, 2013; 126 (1386).
14. Alam M, Siddiqui S, Lee VV, et al. Isolated
coronary artery bypass grafting in obese
individuals: a propensity-matched analysis of
outcomes. Circ J Off J Jpn Circ Soc, 2011; 75 (6):
1378-1385.
15. Tawfek A, Abdel Bary KH, Mostafa Kotb,
Soliman. Impact of obesity on the results of
cardiac surgery in Egypt: early outcomes of
heart valve surgery. J Egypt Soc Cardio Thorac
Surg, 2017; 25 (3): 185 - 191.
16. Al Salmi H, Elmahrouk A, Arafat A, et al.
Implementation of an evidence-based practice
to decrease surgical site infection after
coronary artery bypass grafting. Journal of
International Medical Research; 2019,
0300060519836511. 
17. Rajaei S, Dabbagh A. Risk factors for
postoperative respiratory mortality and
morbidity in patients undergoing coronary
artery bypass grafting. Anesth Pain Med. 2012;
2 (2): 60-65.
